A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE-Reference-Cited by-同舟云学术

A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE

Published:2018-03-06 Issue:6 Volume:19 Page:475-483
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Zhang Jian¹,Li Huizhong¹,Gao Dazhi¹²,Zhang Baofu¹,Zheng Maojin³,Lun Mingyin¹,Wei Mengxue¹,Duan Rui¹,Guo Maomao¹,Hua Jiajun¹,Liu Qian¹,Bai Jin¹,Liu Hui³⁴,Zheng Junnian¹⁴,Yao Hong¹

Affiliation:

1. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China

2. The Department of Radiology, Nanjing General Hospital, Nanjing Military Command of PLA, Nanjing, Jiangsu, China

3. Department of Pathology, School of Biomedical Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China

4. The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

Funder

Joint program between the Science and Technology Department of Yunnan Province and Kunming Medical University

The Major Programs of Nature Science Project of the Eduction Department of Jiangsu Province

National Natural Science General Program

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1433501

Reference36 articles.

1. Management of HCC

2. Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion

3. Hepatocellular Carcinoma

4. Hepatocellular carcinoma pathogenesis: from genes to environment

5. A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection For HCC Conforming to the Milan Criteria

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights in Molecular Therapies for Hepatocellular Carcinoma;Cancers;2024-05-10

2. Dendritic cell-cytokine killer combined with microwave ablation reduced recurrence for hepatocellular carcinoma compared to ablation alone;Technology and Health Care;2024-05-10

3. The Therapeutic Potential of Cytokine-Induced Killer in Patients with Cancer;Journal of Interferon & Cytokine Research;2024-03-01

4. Combination treatment of pembrolizumab with DC-CIK cell therapy for Advanced hepatocellular carcinoma: a case report;BioMedicine;2023-08-28

5. ASF1B, as an Independent Prognostic Biomarker, Correlates with Immune Infiltrates in Hepatocellular Carcinoma;Combinatorial Chemistry & High Throughput Screening;2023-06